Proteasome inhibitors reduce thrombospondin-1 release in human dysferlin-deficient myotubes

BACKGROUND: Dysferlinopathies are a group of muscle disorders causing muscle weakness and absence or low levels of dysferlin, a type-II transmembrane protein and the causative gene of these dystrophies. Dysferlin is implicated in vesicle fusion, trafficking, and membrane repair. Muscle biopsy of pat...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Musculoskelet Disord
Autori principali: Fernández-Simón, Esther, Lleixà, Cinta, Suarez-Calvet, Xavier, Diaz-Manera, Jordi, Illa, Isabel, Gallardo, Eduard, de Luna, Noemí
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2020
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7697384/
https://ncbi.nlm.nih.gov/pubmed/33246442
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12891-020-03756-7
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi